Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation. (Q46034890)
Jump to navigation
Jump to search
scientific article published on 3 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation. |
scientific article published on 3 May 2009 |
Statements
Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation (English)
Mathieu Laplante
Sophie Brûlé
Vanessa P Houde
Adel Achouba
Dominic Lachance
Maria L Pedrosa
Marcelo E Silva
Renata Guerra-Sá
Jacques Couet
Marie Arsenault
André Marette
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference